Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$100,235,643
+$42,491,770 QoQ
Shares Held
201,791
+56.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
12.33%
of 13F equity value
Holder Rank
#115
of 1,742 holders
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tri Locum Partners LP holds $480,651,345 across 12 Biotechnology names. VRTX ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
201,791 | $100,235,643 | |
| 2 | ASND |
Ascendis Pharma A/S
|
258,740 | $69,011,132 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
219,308 | $53,680,019 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
221,720 | $53,427,868 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
866,716 | $43,985,837 | |
| 6 | ARGX |
Argenx SE
|
41,596 | $38,591,520 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
68,273 | $36,659,187 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
151,822 | $28,433,224 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,235,643 | 201,791 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $57,743,873 | 129,314 | Shares | Sole | 2026-05-18 | |
| 2024-03-31 | $14,880,319 | 35,598 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $8,655,930 | 24,597 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||